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Abstract 30	  
Although there is no acute luteolytic mechanism in the absence of pregnancy in the bitch a 31	  
precise and well-timed embryo-maternal interaction seems to be required for the initiation and 32	  
maintenance of gestation. Since only limited information is available about these processes in 33	  
dogs, here, the uterine expression of possible decidualization markers was investigated during the 34	  
pre-implantation stage (days 10-12) of pregnancy and in corresponding non-pregnant controls. 35	  
Additionally, the expression of selected genes associated with blastocyst development and/or 36	  
implantation was investigated in embryos flushed from the uteri used for this study (unhatched 37	  
and hatched blastocysts). There was an upregulated expression of prolactin receptor (PRLr) and 38	  
insulin-like growth factor 2 (IGF2) observed pre-implantation. The expression of PRL and of 39	  
IGF1 was unaffected, and neither was the expression of progesterone- or estrogen receptor β 40	  
(ERβ). In contrast, ERα-levels were elevated during early pregnancy. Prostaglandin (PG)-system 41	  
revealed upregulated expression of PGE2-synthase and its receptors, EP2 (PTGER2) and EP4 42	  
(PTGER4), and of the PG-transporter. Elevated levels of PGF2α-synthase (PGFS/AKR1C3) 43	  
mRNA, but not the protein itself, were noted. Expression of prostaglandin-endoperoxide synthase 44	  
2 (PTGS2,COX2) remained unaffected. Most of the transcripts were predominantly localized to 45	  
the uterine epithelial cells, myometrium and, to a lesser extent, to the uterine stroma. PGES 46	  
mRNA was abundantly expressed in both groups of embryos and appeared higher in the hatched 47	  
ones. The expression level of IGF2 mRNA appeared higher than that of IGF1 mRNA in hatched 48	  
embryos. In unhatched embryos IGF1, IGF2 and COX2 mRNA levels were below the detection 49	  
limit.  50	  51	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Introduction 51	  
Establishment and maintenance of pregnancy require synthesis and well-orchestrated secretion of 52	  
a plethora of regulatory factors that establish the uterine milieu needed for embryo implantation 53	  
and development. The vast majority of these factors remain under the control of progesterone, 54	  
which is an essential pleiotropic regulator of uterine function.  55	  
Because there is no placental steroidogenic activity in the dog, the provision of circulating 56	  
progesterone depends on corpora lutea (CL) as the major source of this hormone throughout 57	  
gestation (Concannon et al. 1989). In livestock, e.g., cattle, pigs and horses, it is well established 58	  
that uterine PGF2α is luteolytic and is responsible for terminating the luteal phase of the estrous 59	  
cycle in non-pregnant females; therefore, there is no pseudopregnancy in these animals. In 60	  
contrast to livestock, at least in non-pregnant bitches, there is no uterine luteolysin that could be 61	  
required for normal ovarian cyclicity, since normal ovarian function is observed following 62	  
hysterectomy (Olson et al. 1984, Hoffmann et al. 1992). Furthermore, a luteolytic role of 63	  
intraluteally produced prostaglandins can be ruled out (Kowalewski et al. 2006b, Kowalewski et 64	  
al. 2009). Thus, the absence of an acute luteolytic mechanism in the non-pregnant bitch 65	  
(Concannon et al. 1989, Hoffmann et al. 1992) results in a physiological pseudopregnancy and a 66	  
luteal life span similar to, or even longer than that observed in pregnant bitches. In contrast, in 67	  
pregnant bitches, the steep prepartum progesterone decline is associated with strongly increased 68	  
PGF2α concentrations in the maternal circulation (Nohr et al. 1993), implying its role during 69	  
prepartum luteolysis and/or parturition.  70	  
Prostaglandin E2 (PGE2) is one of the important luteotrophic factors in the dog (Kowalewski et 71	  
al. 2008, Kowalewski et al. 2009, Kowalewski et al. 2013). As recently shown, PGE2 is capable 72	  
of activating progesterone synthesis in canine luteal cells isolated from early developing CL 73	  
acting at the level of steroidogenic acute regulatory (STAR) protein expression and function 74	  
(Kowalewski et al. 2013). Although both luteinizing hormone (LH) and prolactin (PRL) are 75	  
luteotrophic factors, with PRL being the predominant one (Concannon 1980, Okkens et al. 1990, 76	  
Onclin et al. 1993, Onclin et al. 2000), gonadotrophic support does not seem to be required for 77	  
luteal maintenance during the early CL phase (Okkens et al. 1986).  78	  
Consequently, the canine CL seems to possess an inherent life span, resulting in a similar 79	  
progesterone secretion pattern in pregnant and non-pregnant animals which is mirrored in 80	  
circulating progesterone levels that do not differ significantly until shortly before parturition; at 81	  
that time, when a dramatic prepartum progesterone decline is observed, signaling the onset of 82	  
	   4	  
parturition (Concannon et al. 1989). This hormone profile precludes progesterone as a usable 83	  
marker for detection of pregnancy in the bitch. Moreover, no pregnancy-associated increase in 84	  
estrogens is observed in the dog (Hoffmann et al. 1994). 85	  
  86	  
Even though knowledge concerning the endocrine control of the canine reproductive cycle has 87	  
greatly improved, there is still a lack of information concerning the progesterone-dependent 88	  
establishment of the intimate, initial embryo-maternal contact, and the role of the early canine 89	  
embryo during this process. In particular, knowledge about endocrine mechanisms regulating the 90	  
uterine microenvironment prior to implantation is still limited for the dog. This aspect is 91	  
important for the entire early gestational period up until days 17-18 after mating, at which time 92	  
implantation takes place in dogs, immediately followed by the start of placenta formation 93	  
(Amoroso 1952). 94	  
Prior to that, the progesterone-dependent decidualization process starts, which is characterized by 95	  
a very strong, species-specific remodeling of the uterine tissues, especially at the implantation 96	  
sites. As a result of this change, maternal stroma-derived, so-called decidual cells, are the only 97	  
cells of the canine placenta expressing the progesterone receptor (PGR) (Vermeirsch et al. 2000, 98	  
Kowalewski et al. 2010). Interfering with PGR function, e.g., by application of an antigestagen, 99	  
will unequivocally lead to preterm parturition/abortion (Baan et al. 2008, Kowalewski et al. 100	  
2010). 101	  
In some earlier studies aimed at detecting factors possibly contributing to embryo implantation in 102	  
the dog, no differences were found in the expression of heat shock proteins and acute phase 103	  
proteins between the uteri of early pregnant and non-pregnant dogs (Evans & Anderton 1992, 104	  
Buhi et al. 1993, Concannon et al. 1996). Recently CD8, interleukin (IL)4 and interferon gamma 105	  
(IFNγ)-mRNA were found as being abundantly expressed in the early pregnant uterus, while the 106	  
expression of CD4, tumor necrosis factor alpha (TNFα) and IL6 mRNA seemed to be targeted to 107	  
the non-pregnant uterus (Schafer-Somi et al. 2008, Beceriklisoy et al. 2009). In contrast to 108	  
insulin-like growth factor 1 (IGF1), the expression of IGF2 mRNA was found both during early 109	  
pregnancy and in the non-pregnant uterus (Schafer-Somi et al. 2008). Even though these data, 110	  
which are mostly based on qualitative transcriptional analysis studies, still need further 111	  
confirmation, they indicate the differential regulation of the uterine function in the pregnant vs. 112	  
non-pregnant dogs and suggest a possible role of the pre-implantation embryo in this process.  113	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Together with IGF1 and -2, the increased endometrial expression of PRL belongs to the so-called 114	  
markers of decidualization (Irwin et al. 1994, Ramathal et al. 2010). Recently, (Kowalewski et 115	  
al. 2011b) we have speculated that PRL acting through endo- and/or paracrine mechanisms might 116	  
be involved in endometrial glandular secretory function in the dog. Furthermore, Bukowska et al. 117	  
(Bukowska et al. 2011) reported an increased expression of integrins-α2b, -β2 and -β3 and of 118	  
vasoepithelial growth factors (VEGF) -165, -182 and -188 in the uterus of early pregnant bitches.  119	  
Nevertheless, the factors and endocrine pathways regulating the functions of the pregnant uterus 120	  
during the onset of canine pregnancy require further elucidation. Improving our knowledge about 121	  
the establishment and composition of the proper uterine pre-implantation milieu could improve 122	  
understanding of the etiopathogenesis of some frequently occurring diestrual disorders of the 123	  
uterus, such as endometrial hyperplasia complex. This disorder seems to originate from a 124	  
dysregulated endocrinological response of the uterus to hormonal stimulation during the luteal 125	  
phase of the estrous cycle and is considered by many authors as an initial phase in the 126	  
development of pyometra. Furthermore, the poor outcome of in vitro fertilization procedures in 127	  
canids may also be related to an inappropriate oocyte maturation environment, lacking growth 128	  
factors required for acquisition of full embryo developmental competence (Luvoni et al. 2006). 129	  
Consequently, the expression and cellular localization of several genes that are possibly 130	  
differentially regulated during canine early pregnancy, including the so-called decidualization 131	  
markers, were investigated during the pre-implantation stage of pregnancy and in corresponding 132	  
uterine tissues from non-pregnant dogs. During this early stage of pregnancy, the survival and 133	  
development of free-floating embryos are dependent on the intra-uterine environment. The 134	  
expression of E-cadherin (CDH1), a cell adhesion protein, whose decreased expression is 135	  
frequently associated with increased migratory activity of different cell types, was also evaluated. 136	  
Additionally, while limited by availability of the experimental material, the expression of 137	  
selected genes was investigated when possible in embryos flushed from the early pregnant uteri 138	  
used for this study. 139	  
 140	  
Materials and methods 141	  
Tissue collections 142	  
Uterine tissues from eight (n=8) early pregnant (pre-implantation group, days 10-12 of 143	  
pregnancy), crossbreed, healthy bitches were used for this study. The day of mating (Day 0) was 144	  
2-3 days after ovulation, which was determined by vaginal cytology and by progesterone 145	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measurements (>5ng/ml in peripheral blood). The pre-implantation stage of pregnancy was 146	  
confirmed by flushing embryos from uteri. Dogs determined as non-pregnant in the uterine 147	  
flushings served for negative controls (n=6). Uterine samples were collected via 148	  
ovariohysterectomy. All experimental procedures were performed in accordance with animal 149	  
welfare legislation. 150	  
For isolation of RNA, immediately after surgery, uterine tissues (including all anatomical layers) 151	  
were trimmed of surrounding connective tissues and shock-frozen in liquid nitrogen; longer 152	  
storage was at -80°C.  153	  
For immunohistochemistry (IHC) and in situ hybridization (ISH), after surgery tissue samples 154	  
were fixed for 24 hrs at +4°C in 10% neutral phosphate buffered formalin. Afterwards, they were 155	  
washed daily with phosphate buffered saline (PBS) for one week, subsequently dehydrated in a 156	  
graded ethanol series and embedded in paraffin-equivalent Histo-Comp (Vogel, Giessen, 157	  
Germany). 158	  
Additionally, embryos sampled from 5 uteri (n=19) were available for this study. After careful 159	  
evaluation under a stereomicroscope, embryos were classified into two groups: hatched 160	  
blastocysts (n=12, 63%) and unhatched blastocysts (n=7, 37%), and immediately frozen and 161	  
stored at -80°C. 162	  
 163	  
RNA isolation and reverse transcription (RT)  164	  
TRIZOL®-Reagent (Invitrogen, Carlsbad, CA) was used following the manufacturer’s protocol 165	  
in order to isolate total RNA from all samples investigated. The RNA content was measured with 166	  
a NanoDrop 2000 UV-Vis Spectrophotometer® (Thermo Scientific, Wilmington, USA).  167	  
For further purification of the RNA content, DNase treatment with RQ1 RNAse-free DNAse 168	  
(Promega, Dübendorf, CH) was performed following the manufacturer’s instructions. For each 169	  
sample, 100-200ng of DNase-treated total RNA were used in the reverse transcription (RT) and 170	  
complementary DNA (cDNA) was synthesized using RT reagents purchased from Applied 171	  
Biosystems (Foster City, CA, USA) with random hexamers used as primers according to our 172	  
previously published protocol (Kowalewski et al. 2006b, Kowalewski et al. 2011b). All reactions 173	  
were carried out in an Eppendorf Mastercycler® (Vaudaux-Eppendorf AG, Basel, CH). The 174	  
following RT conditions were applied: 8 min at 21°C, then 15 min at 42°C, after which the 175	  
reaction was stopped by incubation for 5 min at 99°C. 176	  
 177	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Homology cloning of canine specific insulin-like growth factor receptor 1 (IGF1R) 178	  
The canine specific IGF1R cDNA had not been characterized prior to this study. Thus, to provide 179	  
required data on the mRNA level, molecular cloning and sequencing were performed. Using an 180	  
online available predicted sequence, canine-specific IGF1R primers were designed and ordered 181	  
from Microsynth AG (Balgach, CH): forward 5’-CTC GAC AAC CAG AAC TTG C-3’ and 182	  
reverse 5’- GTT GTG GCG GTA AAG GTA AC-3’.  183	  
The GeneAmp Gold RNA PCR Kit from Applied Biosystems was used in a hot-start PCR 184	  
reaction according to our previously described protocol (Kowalewski et al. 2006b, Kowalewski 185	  
et al. 2011b). The annealing temperature was 58°C. Total RNA obtained from at least three 186	  
uterine samples was used, and PCR fragments comprising 717bp of partial canine IGF1R were 187	  
successfully amplified. The following negative controls were run for each experiment: autoclaved 188	  
water used instead of cDNA (no template control) and the so-called RT-minus control, i.e., 189	  
samples in which no RT reaction was performed. The PCR products were separated on a 2% 190	  
ethidium bromide stained agarose gel, extracted using a Qiaex II gel extraction system (Qiagen 191	  
GmbH Hilden, Germany), subcloned into pGEM-T vector (Promega, Dübendorf, CH) and 192	  
transformed and amplified in XL1 Blue competent cells (Stratagene, La Jolla, CA, USA). After 193	  
being purified with Pure YieldTM Plasmid MidiPrep System (Promega), bacterial plasmids were 194	  
sequenced on both strands with T7 and Sp6 primers (Microsynth). Finally, the cloned sequence 195	  
was submitted to GenBank with the following accession number: KF793925. 196	  
 197	  
Real Time (TaqMan) PCR and data evaluation 198	  
Real time PCR (TaqMan) analysis was performed in an automated fluorometer ABI PRISM 7500 199	  
Sequence Detection System (Applied Biosystems), in accordance with the manufacturer`s 200	  
instructions and following our previously described protocol (Kowalewski et al. 2010, 201	  
Kowalewski et al. 2011a). The cDNA synthesis and negative controls were as for qualitative 202	  
PCR described above. Fast Start Universal Probe Master (ROX®) (Roche Diagnostics AG, 203	  
Schweiz) was used. The semi-quantitation of target gene expression was performed using three 204	  
independent endogenous reference genes (GAPDH, 18SrRNA and cyclophilin A) in the 205	  
comparative CT method (ΔΔCT method) as described previously (Kowalewski et al. 2010, 206	  
Kowalewski et al. 2011a) and according to the ABI 7500 Fast Real Time PCR System 207	  
manufacturer’s protocol. The efficiencies of the PCR assays were established by the CT slope 208	  
method assuring approximately 100% reaction efficiency. Selected PCR products were sent for 209	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sequencing (Microsynth). Primers and 6-carboxyflurescein (6-FAM) and 6-carboxytertamethyl-210	  
rhodamine (TAMRA)-labelled TaqMan probes, provided by Microsynth, are listed in Table 1. 211	  
The following canine-specific TaqMan Gene Expression Assays were commercially available 212	  
and purchased from Applied Biosystems: cyclophilin A (Prod. No. Cf03986523- gH), E-cadherin 213	  
(CDH1) (Prod. No. Cf02624268_m1), IGF1 (Prod. No. Cf02627846_m1) and IGF2 (Prod. No. 214	  
Cf02647136_m1). 215	  
 216	  
An unpaired, two-tailed Student’s t-test was performed to compare the levels of target genes in 217	  
uterine samples from early pregnant and non-pregnant control dogs. Numerical data are presented 218	  
as the mean ± standard deviation (S.D.). Due to the uneven distribution of the Real Time PCR 219	  
data obtained for expression of LH-receptor (LHR), IGF1R and oxytocin receptor (OTR), results 220	  
are presented as geometric means with deviation factor (Xg . DF±1). The statistical software 221	  
program GraphPad 3.06 (GraphPad Software, San Diego, CA, USA) was used. P < 0.05 was 222	  
considered statistically significant. 223	  
 224	  
Immunohistochemistry 225	  
Formalin-fixed, paraffin-embedded uterine cross-sections (2-3µm thick) from early pregnant and 226	  
non-pregnant bitches, mounted on SuperFrost Plus microscope slides (Menzel-Gläser, 227	  
Braunschweig, Germany), were subjected to the standard immunoperoxidase detection method 228	  
following our previously described protocol (Kowalewski et al. 2006a, Kowalewski et al. 2010, 229	  
Gram et al. 2013a). The list of primary and secondary antibodies and of the respective IgG 230	  
irrelevant antibodies (negative/isotype controls) is presented in Table 2. Additionally, slides 231	  
omitting the primary antibodies served as negative controls. The nonspecific binding sites were 232	  
blocked with either 10% horse serum or 10% normal goat serum, depending on the secondary 233	  
antibody used in experiments. Peroxidase activity was detected using Liquid DAB+ substrate kit 234	  
(Dako Schweiz AG, Baar, CH). Sections were counterstained with hematoxylin and embedded in 235	  
Histokit (Assistant, Osterode, Germany) 236	  
 237	  
In situ hybridization (ISH) 238	  
According to the previously described protocol (Kowalewski et al. 2006a, Gram et al. 2013a), 239	  
non-radioactive ISH on paraffin-embedded sections was performed in order to investigate the 240	  
uterine cellular localization of IGF1 and IGF2 at the mRNA level. 241	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PCR products generated with the following primers were used for subsequent synthesis of the 242	  
digoxigenin (DIG)-labeled cRNA probes: IGF1 (forward) 5'- GGT GGA CGC TCT TCA GTT C 243	  
-3', IGF1 (reverse) 5'- TCC TGC ACT CCC TCT ACT TG -3' (product length 268bp, annealing 244	  
temperature 60°C) and IGF2 (forward) 5'- GTG CTG CTT TGC TGC TTA C -3', IGF2 (reverse) 245	  
5'- GGG TAT CTG GGG AAG TTG TC -3' (product length 251 bp, annealing temperature 246	  
60°C). The DIG-labelled cRNA was detected using alkaline phosphatase conjugated sheep anti-247	  
DIG Fab Fragments (Roche Diagnostics) at 1:5,000 dilution in 1% ovine serum according to the 248	  
manufacturer’s instructions. Signals were detected with the substrate 5-bromo-4-chloro-3-indolyl 249	  
phosphate and nitroblue tetrazolium (NBT/BCIP; Roche Diagnostics). 250	  
 251	  
Results 252	  
Temporal expression of selected genes in canine uterine tissues during the pre-implantation 253	  
stage of pregnancy  254	  
Expression of several genes, as listed in Table 1, was investigated at both the mRNA and protein 255	  
levels in uteri of early pregnant animals (pre-implantation) and compared with their expression in 256	  
corresponding tissues from non-pregnant dogs (non-pregnant controls). 257	  
Expression of all the selected genes was detectable in tissue samples obtained from early-258	  
pregnant and non-pregnant dogs. A significantly higher expression of IGF2 and PRLr mRNA 259	  
was observed in the early pregnant uterus (P=0.04 and P=0.02, respectively) compared to the 260	  
controls (Fig. 1). The opposite effect was observed for the uterine expression of LHR, which was 261	  
significantly downregulated during early pregnancy (P=0.01) (Fig.1). However, the expression of 262	  
IGF1, IGF1R and PRL mRNA remained unaffected (P=0.5, P=0.47 and P=0.42, respectively) by 263	  
uterine exposure to embryos (Fig. 1). In addition, PRL-mRNA was generally expressed at a very 264	  
low level, and was frequently below the detection limit in both groups of animals.  265	  
Among the steroid hormone receptors, only the expression of estrogen receptor alpha (ERα) was 266	  
significantly (P=0.03) elevated in the early pregnant uterus (Fig. 2), while expression of the 267	  
progesterone receptor (PGR) and of ERβ did not differ between the two groups (P=0.27 and 268	  
P=0.23, respectively). Similarly, expression of the oxytocin receptor (OTR), which varied widely 269	  
among individuals in both groups, was unaffected (P=0.5) by the reproductive status of the 270	  
animals. The expression of E-cadherin (CDH1) did not differ (P=0.25). 271	  
Concerning expression of the major members of the prostaglandin (PG) system, no statistically 272	  
significant differences were observed for the expression of mRNA encoding for the 273	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prostaglandin-endoperoxide synthase 2 (PTGS2, formerly known as COX2) (P=0.8), the PGE2 274	  
receptor designated as EP4 (PGER4) (P=0.21), and 15-hydroxy prostaglandin dehydrogenase 275	  
(HPGD) (P=0.29) (Fig. 3 A,D and Fig. 4D). In contrast, a significant upregulation was noted for 276	  
mRNA expression of PGE2-synthase (PGES) (P=0.04) and PGF2α-synthase (PGFS/AKR1B3) 277	  
(P=0.007), as well as of their respective receptors, EP2 (PTGER2) (P=0.02) and FP (PTGFR) 278	  
(P=0.02) and of the PG-transporter (PGT) (P=0.02), in the pre-implantation uterus compared with 279	  
non-pregnant uterus (Fig. 3B,C and 4 A-C).  280	  
 281	  
Localization of gene expression  282	  
In the pre-implantation uterus immunohistochemistry clearly localized IGF2 protein expression 283	  
to the surface epithelial cells and to the epithelial cells of the superficial and deep uterine glands; 284	  
clearly detectable signals were also localized in the myometrium. Weaker signals were observed 285	  
in the endometrial stroma (Fig. 5 B,C). No, or only very weak immunohistochemical signals were 286	  
observed for IGF2 expression in the uteri of non-pregnant dogs (Fig. 5 A). A localization pattern 287	  
similar to this but in both early pregnant and non-pregnant uteri was observed at the mRNA level 288	  
by using ISH (Fig. 5. H,I). As also determined by ISH, IGF1 expression was co-localized with 289	  
uterine IGF2 expression (Fig. 5 H,I). There was no anti-IGF1 canine-specific antibody available 290	  
for the immonohistochemical studies. The IGF1R protein expression followed the IGF1 and 291	  
IGF2 distribution pattern with stronger signals observed in the early pregnant uterus (Fig. 5 D,E).  292	  
While weaker endometrial signals were observed for PRLr protein expression in non-pregnant 293	  
animals (Fig. 6 A,B), stronger signals were detected in the surface and glandular endometrial 294	  
epithelial cells of the early pregnant uterus (Fig. 6 C,D). Clear myometrial staining was noted in 295	  
both groups of animals (Fig. 6 B,D).  296	  
Expression of PGR was detectable in the uteri of both early-pregnant and control animals but did 297	  
not vary widely between the two groups. The immunohistochemical signals were localized to 298	  
nuclei of both superficial and glandular epithelial cells, as well as the smooth muscle cells of the 299	  
myometrium and to a lesser extent in the endometrial stroma (Fig. 7 A,B).  300	  
The ERα protein was co-localized with PGR, however, signals were distinctly stronger in uteri 301	  
after embryo exposure than in the non-pregnant controls (Fig. 7 C,D). Much weaker staining was 302	  
observed for uterine ERβ expression which did not differ between the two groups and showed a 303	  
similar localization pattern as for the other nuclear receptors (Fig. 7 E,F). 304	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Whereas endometrium stained negatively for COX2, however, myometrial signals were strong 305	  
(Fig. 8 A), but no or only very weak uterine signals were observed for PGFS/AKR1C3 protein, in 306	  
both groups of animals (Fig. 8 B).  307	  
The expression of PGT, PGES, EP2 and EP4 revealed a similar protein distribution pattern as 308	  
PRLr, showing their co-localization and higher abundance in endometrial epithelial cells, the 309	  
myometrium and stromal cells in the pre-implantation uterus (Fig. 8 C,D and 9 A-F). For all 310	  
these factors, staining in the endometrial stroma was weaker than in the epithelial compartments. 311	  
High variability for the HPGD immunohistochemical signals was observed between individual 312	  
animals in both groups. They tended, however, to be stronger in the early-pregnant uteri and 313	  
revealed a similar localization pattern, but with distinctly stronger staining in the deep uterine 314	  
glands (Fig. 8 E-G). 315	  
 316	  
Expression of selected genes in early, free-floating canine embryos prior to implantation  317	  
Due to the limited availability of the embryo material, investigations were restricted to detecting 318	  
the expression of IGF1, IGF2, COX2 and PGES in the two groups of embryos (unhatched and 319	  
hatched blastocysts) collected from five early pregnant bitches. Embryos were pooled in order to 320	  
reach the required limits of detection. Consequently, no statistical analysis of gene expression 321	  
was possible. 322	  
Whereas the expression of IGF1, IGF2 and COX2 mRNA was below the detection limit in the 323	  
unhatched embryos, the PGES mRNA was abundantly expressed and detectable in both 324	  
unhatched and hatched blastocysts, with apparently higher expression level in the latter ones (Fig. 325	  
10A). The expression of IGF2 mRNA seemed to be higher than that of IGF1 mRNA in the 326	  
hatched group of embryos (Fig. 10 B), while COX2 and PGES showed similar transcript 327	  
abundance (Fig. 10 C).  328	  
 329	  
Discussion 330	  
The uterine response to early embryo exposure was investigated during the pre-implantation 331	  
stage of canine pregnancy by measuring the expression of several target genes. Our investigations 332	  
were based on the assumption that, in view of the lack of an anti-luteolytic signal in the dog 333	  
resulting in similar hormonal status in early-pregnant and non-pregnant dioestric bitches, some 334	  
local effects would be exerted by the early pre-implantation embryo that modify the uterine 335	  
milieu, serving as a prerequisite for a successful implantation and ensuring embryo survival prior 336	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to attachment. The effects of seminal plasma-derived bioactive factors in modulation of the 337	  
uterine endocrine milieu, and possibly having an impact on the initiation of pregnancy in dogs, 338	  
were not separately investigated in this study, but would certainly merit future investigations. 339	  
Among the genes investigated, IGF1, IGF2 and PRL count as the most prominent and well-340	  
characterized markers of the decidualization process (Irwin et al. 1994, Ramathal et al. 2010). By 341	  
interacting mainly with the IGF1R (Wang & Chard 1999), both IGF1 and IGF2 are mitogenic 342	  
factors whose uterine expression is regulated by steroidogenic hormones (De Cock et al. 2002, 343	  
Bhatti et al. 2007, Dantzer & Swanson 2012). They possess differentiative properties capable of 344	  
influencing embryonic development, as shown, e.g., in humans and ruminants (Wathes et al. 345	  
1998, Irwin et al. 1999, Kim et al. 2008). Additionally, in human decidua for example, IGF1 346	  
regulates PRL and arachidonic acid secretion (Handwerger et al. 1991), the latter serving as a 347	  
common precursor for prostaglandin synthesis.  348	  
As for the early pregnant canine uterus investigated in the present study, only the expression of 349	  
IGF2 was significantly upregulated. This was concomitant with the greater abundance of IGF2 350	  
transcripts in hatched embryos collected at days 10-12 of canine pregnancy, suggesting the 351	  
predominant role of IGF2 compared to IGF1, during this very early stage of pregnancy in the 352	  
dog. In contrast to the unaffected IGF1R-mRNA expression levels, which varied widely among 353	  
individuals, expression of the respective protein was clearly detectable and seemed to be more 354	  
strongly expressed during early pregnancy, implying the involvement of posttranscriptional 355	  
regulatory mechanisms in its expression. 356	  
The uterine expression of PRLr, but not of PRL, was strongly upregulated after embryo exposure 357	  
pre-implantation. This finding agrees with our previous report about the uterine and placental 358	  
expression of PRLr (Kowalewski et al. 2011b), implying the possible role of PRLr-mediated 359	  
effects in endometrial glandular secretory activity during the production of uterine milk 360	  
(histiotrophe), a mechanism that was also suggested for humans (Jabbour et al. 1998). Our 361	  
previous observation that interfering with progesterone receptor function by applying an 362	  
antigestagen results in a decreased utero/placental PRLr expression, suggests that this involves 363	  
progesterone-mediated effects (Kowalewski et al. 2011b). In the present study, although uterine 364	  
PRL expression was relatively low, and frequently even below the detection limit, possible 365	  
paracrine effects of locally produced PRL cannot be ruled out. Its contribution to circulating PRL 366	  
levels does not seem, however, very likely. In contrast to PRLr expression, the expression of 367	  
LHR was downregulated in the early pregnant canine uterus. Recently, the role of LHR was 368	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suggested as a possible important factor contributing to the implantation process in mice 369	  
(Gridelet et al. 2013). While any final conclusion concerning LHR function during the onset of 370	  
canine pregnancy would be premature, we believe that this warrants further investigations. 371	  
Besides acting as one of the most potent uterotonic hormones, oxytocin also regulates secretion 372	  
of other hormones, e.g., prostaglandins (Meier et al. 1995, Fuchs et al. 1999). This prompted us 373	  
to investigate expression of the oxytocin receptor (OTR) in the early pregnant uterus and its 374	  
corresponding non-pregnant counterpart. Most recently (Gram et al. 2013b), OTR was localized 375	  
by our group to the uterine surface epithelium of the pre-implantation uterus, specifically in the 376	  
superficial and deep glands and the vascular endothelial and stromal cells. In the present study, 377	  
however, OTR expression varied widely among individuals and, consequently, did not differ 378	  
significantly between the two groups, thereby not allowing any further conclusions to be drawn 379	  
regarding its potential secretory or constrictory activity during the onset of canine pregnancy. 380	  
Such activity could relate, e.g., to mechanisms involved in the distribution and positioning of 381	  
free-floating embryos prior to attachment, or to the role of oxytocin as a mediator of local 382	  
prostaglandin effects. 383	  
The expression of COX2 (PTGS2), the rate-limiting factor in the provision of prostaglandins, and 384	  
of PGFS/AKR1C3 protein, was low in the early dioestric uterus and remained unaffected by the 385	  
presence of embryos. The PGFS/AKR1C3 is the only canine-specific isoform of PGFS known to 386	  
date and is responsible for the direct conversion of PGH2 to PGF2α (Gram et al. 2013a). Since 387	  
expression of the respective mRNAs was significantly increased in early pregnancy, some local 388	  
effects and possible involvement of posttranscriptional regulatory mechanisms cannot be 389	  
excluded, especially in view of the concomitantly increased expression of the PGF2α-receptor 390	  
(FP, PTGFR). In contrast, the expression of PGES was significantly affected both at the mRNA 391	  
and protein levels in response to early embryo exposure, which together with the upregulated 392	  
expression of PGT further implies local effects of prostaglandins. This conclusion also agrees 393	  
with our prior report suggesting a role of prostaglandins in canine decidualization, placentation 394	  
and, later on, in trophoblast invasion (Kowalewski et al. 2010, Gram et al. 2013a). The low levels 395	  
of COX2 expression, together with clearly detectable uterine HPGD expression (the enzyme 396	  
responsible for conversion of PGE2 and PGF2α to their inactive metabolites) in pregnant and 397	  
non-pregnant uteri, could additionally coordinate and restrict the effects of prostaglandins as local 398	  
regulatory factors.  399	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Acting through its two G protein coupled receptors designated EP2 (PTGER2) and EP4 400	  
(PTGER4), PGE2 exerts its roles mostly through the cAMP/PKA signaling pathway (Christenson 401	  
et al. 1994, Boiti et al. 2001, Harris et al. 2001, Arosh et al. 2004). Also, progesterone-dependent 402	  
decidualization is cAMP-mediated and this process is accelerated by PGE2 in human endometrial 403	  
stromal cells (Brar et al. 1997). Similar effects of PGE2 and its potential to stimulate the decidual 404	  
cell reaction were observed in rats (Kennedy & Doktorcik 1988). This could also be true for the 405	  
canine species, as indicated in the present study by the increased uterine synthesis of PGES, EP2, 406	  
and also EP4 protein, concomitant with the higher PGES expression in hatched embryos, 407	  
possibly actively contributing to the decidualization process.  408	  
It is noteworthy that in the uterine samples investigated in the present study, derived from both 409	  
early pregnant and non-pregnant bitches, stronger immunohistochemical signals were localized in 410	  
the endometrial epithelial compartments. On the other hand, weaker signals were observed in the 411	  
uterine stromal cells that undergo a strong, species-specific decidualization process later on in 412	  
canine gestation. This, together with the unaffected IGF1 and strongly varying IGF1R mRNA 413	  
expression in the pre-implantation uterus, seems to be an indicator of the early stage of uterine 414	  
differentiation at the beginning of pregnancy (gestational days 10-12) observed in our study. At 415	  
this time, the uterine morphology is characterized by obvious embryo-induced functional changes 416	  
reflected in the modified uterine milieu observed here, but does not yet exhibit the very strong 417	  
structural changes related to the intense remodeling of uterine tissues that occur later in gestation, 418	  
especially during decidua formation at the implantation sites. This is also indicated by the 419	  
unaffected expression of E-cadherin (CDH1).	  	  420	  
 421	  
Taken together with some earlier studies, our investigations describe the expression of genes that 422	  
are differentially regulated in response to the presence of free-floating embryos in the uterine 423	  
lumen of early pregnant dogs and provide a basis for better understanding of the uterine milieu 424	  
required for proper embryo development and, thereby, for successful establishment of canine 425	  
pregnancy. Elucidating possible functional interactions between these factors, e.g., their role in 426	  
uterine growth and secretory activity, could be helpful in understanding some pathological 427	  
conditions connected with dysregulated endocrinological responses of the uterus, that are 428	  
frequently caused by impaired cross-talk between growth factors and hormones.  429	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Figure legends: 596	  
 597	  
Figure 1.  598	  
Expression of insulin-like growth factor 1 (IGF1), IGF2, IGF-receptor 1 (IGF1R), prolactin 599	  
(PRL) and its receptor (PRLr), and luteinizing hormone receptor (LHR) as determined by Real 600	  
Time (TaqMan) PCR in uterine samples from early-pregnant uterus (pre-implantation; embryo-601	  
induced effects), and its non-pregnant counterparts. Numerical data are presented either as the 602	  
mean ± standard deviation (SD) (A,C-E), or as geometric means with deviation factor (Xg . 603	  
DF±1) (B, F). Bars with (*) differ at: (C) P=0.04, (E) P=0.02, (F) P=0.01. 604	  
 605	  
Figure 2. 606	  
Expression of estrogen receptor alpha (ERα), ERβ, progesterone receptor (PGR), oxytocin 607	  
receptor (OTR) and E-cadherin (CDH1) as determined by Real Time (TaqMan) PCR in uterine 608	  
samples from early-pregnant uterus (pre-implantation; embryo-induced effects), and its non-609	  
pregnant counterparts. Numerical data are presented either as the mean ± standard deviation (SD) 610	  
(A-C und E), or as geometric means with deviation factor (Xg . DF±1) (D). Bar with (*) in (A) 611	  
differ at: P=0.03. 612	  
 613	  
Figure 3. 614	  
Expression of cyclooxygenase 2 (COX2, PTGS2), prostaglandin E2 (PGE2)-synthase (PGES) and 615	  
of PGE2 receptors, EP2 and EP4 (PTGER2 and PTGER4, respectively) as determined by Real 616	  
Time (TaqMan) PCR in uterine samples from early-pregnant uterus (pre-implantation; embryo-617	  
induced effects), and its non-pregnant counterparts. Numerical data are presented as the mean ± 618	  
standard deviation (SD). Bars with (*)  differ at: (B) P=0.04, (C) P=0.02. 619	  
 620	  
Figure 4. 621	  
Expression of prostaglandin F2α (PGF2α)-synthase (PGFS/AKR1C3), PGF2α-receptor (FP, 622	  
PTGFR), prostaglandin transporter (PGT) and of 15-prostaglandin dehydrogenase (HPGD) as 623	  
determined by Real Time (TaqMan) PCR in uterine samples from early-pregnant uterus (pre-624	  
implantation; embryo-induced effects), and its non-pregnant counterparts. Numerical data are 625	  
presented as the mean ± standard deviation (SD). Bars with (*) differ at: (A) P=0.007, (B) 626	  
P=0.02, (C) P=0.02. 627	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 628	  
Figure 5. 629	  
Immunohistochemical (IHC) localization of insulin-like growth factor 2 (IGF2) (A-C) and IGF 630	  
receptor 1 (IGF1R) (D,E), in early pregnant (pre-implantation) canine uterus and corresponding 631	  
non-pregnant uterus. The localization of IGF1 (F,G) and IGF2 (H,I) mRNA expression is 632	  
presented by in situ hybridization (ISH). Solid arrows = superficial (luminal) uterine epithelium, 633	  
open arrows = superficial uterine glands, solid arrowheads = deep uterine glands, open 634	  
arrowheads = myometrium. The inset to (A) shows a representative IgG isotype control for anti-635	  
rabbit immune serum. 636	  
 637	  
Figure 6. 638	  
Immunohistochemical (IHC) localization of prolactin receptor (PRLr) in early pregnant (pre-639	  
implantation) canine uterus (C,D) and corresponding non-pregnant uterus (A,B). Solid arrows = 640	  
superficial (luminal) uterine epithelium, open arrows = superficial uterine glands, solid 641	  
arrowheads = deep uterine glands, open arrowheads = myometrium. The inset to (A) shows a 642	  
representative IgG isotype control for anti-goat immune serum. 643	  
 644	  
 645	  
Figure 7. 646	  
Immunohistochemical (IHC) localization of progesterone receptor (PGR) (A,B), estrogen 647	  
receptor alpha (ERα) (C,D) and ERβ (E,F) in early pregnant (pre-implantation) canine uterus and 648	  
corresponding non-pregnant uterus. Solid arrows = superficial (luminal) uterine epithelium, open 649	  
arrows = superficial uterine glands, solid arrowheads = deep uterine glands. Insets to D and F 650	  
show the myometrial expression of ERα and ERβ, respectively. The inset to (A) shows a 651	  
representative IgG isotype control for anti-mouse immune serum. 652	  
 653	  
 654	  
Figure 8. 655	  
Immunohistochemical (IHC) localization of cyclooxygenase 2 (COX2, PTGS2) (A), 656	  
prostaglanding F2α-synthase (PGFS/AKR1C3) (B) in early pregnant (pre-implantation) canine 657	  
and of prostaglandin transporter (PGT) (C,D) and 15-prostaglandin dehydrogenase (HPGD) (E-658	  
G) in early pre-implantation uterus and corresponding non-pregnant uterus. Solid arrows = 659	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superficial (luminal) uterine epithelium, open arrows = superficial uterine glands, solid 660	  
arrowheads = deep uterine glands. Insets in B, D and G show the myometrial expression of 661	  
PGFS/AKR1C3, PGT and HPGD, respectively.  662	  
  663	  
Figure 9.  664	  
Immunohistochemical (IHC) localization of prostaglandin E2 - synthase (PGE2-synthase, PGES) 665	  
(A,B), PGE2-receptors EP2 (PTGER2) and EP4 (PTGER4) (C,D) and (E,F), respectively, in the 666	  
early pregnant (pre-implantation) canine uterus and corresponding non-pregnant uterus. Solid 667	  
arrows = superficial (luminal) uterine epithelium, open arrows = uterine glands. Insets to B, D 668	  
and F show the myometrial expression of PGES, EP2 and EP4, respectively. The inset to (A) 669	  
shows a representative IgG isotype control for anti-guinea pig immune serum. 670	  
 671	  
 672	  
Figure 10. 673	  
Embryonal expression of prostaglandin E2-synthase (PGES), cyclooxygenase 2 (COX2, PTGS2), 674	  
insulin-like growth factor 1 (IGF1) and IGF2 as determined by Real Time (TaqMan) PCR. 675	   	  676	  
Tables:	  677	  
Table 1. 678	  
List of primers and TaqMan Probes used for the semi-quantitative RT-PCR 679	  
 680	  
Table 2. 681	  
List of antibodies used for the immunohistochemistry 682	   	  683	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PGES	  
Primer Accession 
numbers 
Primer Sequence Product 
 lenght (bp) 
GAPDH (forward) AB028142 5'-GCT GCCAAATAT GACGACATC A-3' 75bp 
GAPDH (reverse)   5'-GTA GCC CAG GAT GCC TTT GAG-3'    
GAPDH (TaqMan Probe)    5'-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3'   
18SrRNA (forward) FJ797658 5'-GTC GCT CGC TCC TCT CCT ACT-3' 125bp 
18SrRNA (reverse)   5'-GGC TGA CCG GGT TGG TTT-3'   
18SrRNA (TaqMan Probe)   5'-ACA TGC CGA CGG GCG CTG AC-3'   
IGF1R (forward) XM545828 5'-GGA CGT TGA GCC TGG CAT T-3'  119bp 
IGF1R (reverse)   5'- CAC TCT TAG CCC CAC GGA TGT-3',   
IGF1R (TaqMan Probe)   5'- AGC CCT GGA CGC AGT ATG CGG -3   
PRLr (forward) HQ267784 5'-GGA TCT TTG TGG CCG TTC TTT-3'  92bp 
PRLr (reverse)   5'-AAG GAT GCA GGT CAC CAT GCT AT-3'   
PRLr (TaqMan Probe)   5'-ATT ATG GTC GTA GCA GTG GCT TTG AAA GGC-3'   
PRL (forward) NM_00108275  5'-CAA GCC CAA CAG ATC CAC CAT-3‘  104bp 
PRL (reverse)   5‘-ATC CCC CGC ACT TCT GTG A-3'   
PRL (TaqMan Probe)     5‘- CTG AGG GTG CTG CGC TCC TGG -3‘   
PGR (forward) NM_001003074 5'-CGA GTC ATT ACC TCA GAA GAT TTG TTT -3'  113bp 
PGR (reverse)   5'- CTT CCA TTG CCC TTT TAA AGA AGA-3'   
PGR (TaqMan Probe)   5'- AAG CAT CAG GCT GTC ATT ATG GTG TCC TAA CTT-3'   
ERα (forward) XM533454 5'-CCC ATG GAG GAG ACA AAC CA -3'  93bp 
ERα (reverse)   5'-CCC TGC CTC CTC GGT GAT ATA -3'   
ERα (TaqMan Probe)   5'-CAC GGG CCC AAC TTC ATC ACA TTC C -3'   
ERβ (forward) XM861041 5'-CCC AGC ACG CCC TTC A -3'  78bp 
ERβ (reverse)   5'-AAT CAT ATG CAC GAG TTC CTT GTC -3'   
ERβ (TaqMan Probe)   5'-CCT CCA TGA TGA TGT CCC TGA CC-3'   
COX2 (forward) HQ110882 5'- GGA GCA TAA CAG AGT GTG TGA TGT G-3'  87bp 
COX2 (reverse)   5'- AAG TAT TAG CCT GCT CGT CTG GAA T-3'   
COX2 (TaqMan Probe)   5'- CGC TCA TCA TCC CAT TCT GGG TGC -3'   
PGFS (forward) NM_001012344 5'-AGG GCT TGC CAA GTC TAT TGG -3'  74bp 
PGFS (reverse)   5'-GCC TTG GCT TGC TCA GGA T -3'   
PGFS (TaqMan Probe)   5'- TCC AAC TTT AAC CGC AGG CAG CTG G-3'   
PGES (forward) NM_001122854 5'-GTC CTG GCG CTG GTG AGT -3'  89bp 
PGES (reverse)   5'- ATG ACA GCC ACC ACG TAC ATC T-3'   
PGES (TaqMan Probe)   5'-TCC CAG CCT TCC TGC TCT GCA GC -3'   
PTGFR (FP) (forward) NM_001048097 5'- ACC AGT CGA ACA TCC TTT GCA-3'  86bp 
PTGFR (FP) (reverse)   5'- GGC CAT CAC ACT GCC TAG AAA-3'   
PTGFR (FP) (TaqMan Probe)   5'-CAT GGT GTT CTC CGG TCT GTG CCC -3'   
PTGER2 (forward) AF075602 5'- CAC CCT GCT GCT GCT TCT C-3'  78bp 
PTGER2 (reverse)   5'- CGG TGC ATG CGG ATG AG-3'   
PTGER2 (TaqMan Probe)   5'-TGC TCG CCT GCA ACT TTC AGC GTC -3'   
PTGER4 (forward) NM_001003054 5'- AAA TCA GCA AAA ACC CAG ACT TG-3'  96bp 
PTGER4 (reverse)   5'-GCA CGG TCT TCC GCA GAA -3'   
PTGER4 (TaqMan Probe)   5'-ATCCGA ATT GCT GCT GTG AAC CCT ATC C -3'   
PGT (forward) NM_001011558 5′-TGC AGC ACT AGG AAT GCT GTT C-3′  116bp 
PGT (reverse)   5′-GGG CGC AGA GAA TCA TGG A-3′   
PGT (TaqMan probe)   5′-TCT GCA AAC CAT TCC CCG CGT G-3′   
HPGD (forward) NM_001284477 5'-GGC AGC GAA TCT CAT GAA CAG-3' 93bp 
HPGD (reverse)   5'- TCT TCT TTC TCA ATG GAT TCA AGGA-3'   
HPGD (TaqMan Probe)   5'- TGA ATG CCA TTT GCC CAG GCT TTG-3'   
OXTR (forward) NM_001198659 5'- GGA TCA CGC TCT CCG TCT ACA-3' 98bp 
OXTR (reverse)   5'-CGT CTT GAG TCG CAG GTT CTG-3'   
OXTR (TaqMan Probe)   5'- CCT GCT ACG GCC TCA TCA GCT TCA A-3'   
LHR (forward) XM538486 5'- TCA TCA TTT GTG CTT GCT ACA TTA AA-3'  98bp 
LHR (reverse)   5'- CGC CAT TTT CTT AGC AAT CTT TG-3'   
LHR (TaqMan Probe)    5'- TGC AGT TCA AAA TCC AGA GCT GAT GGC-3'   
Table	  1	  
Name/Antigen Clone Company Immunogen Concentration Species / Type 
IGFR1 Ibs-0227R Bioss Inc. 
MA, USA 
Ab against 
human IGFR1 
1:800 
 
rabbit 
polyclonal 
IGF2 IGF-II (H103) 
Sc-5622 
Santa Cruz 
Biotechnology 
CA, USA 
Ab against human IGF-2 1:200 rabbit 
polyclonal 
PGR clone 10A9 Immunotech 
Hamburg 
Germany 
Ab against human C-terminal PGR 1:100 mouse 
monoclonal 
 
ERα NCL-ER-6F11 Novo Castra 
New Castle 
UK 
Ab against humanERα 1:10 mouse 
monoclonal 
ERβ MCA 1974 Serotec 
Germany 
Ab against human ERβ 1:20 mouse 
monoclonal 
PRLr catalog no. 
 AF 1167 
R&D Systems 
Europe Ltd. 
NSO-derived rhProlactin R 
extracellular domain 
1:50 goat 
polyclonal 
COX2 clone 33 BD Pharmingen 
Heidelberg 
Germany 
anti-rat COX-2 IgG 1:100 mouse 
monoclonal 
PGT (G-17) 
Sc-103085 
Santa Cruz 
Biotechnology 
CA, USA 
IgG against human PGT 1:100 goat 
polyclonal 
PGFS/AKR1C3 custom made  
canine-specific antibody 
(Gram et al., 2013)   
Eurogentec 
Seraing 
Belgium 
IgG against canine-specific peptide 
sequence DTLFATHPDYPFNDED,  
C-terminal amino acids 309-324 
1:750 guinea pig 
polyclonal 
PGES custom made  
canine-specific antibody   
Eurogentec 
Seraing 
Belgium 
IgG against canine-specific peptide 
sequence RSDQDVDRCLRAHRND,  
C-terminal amino acids 61-76 
1:300 guinea pig 
polyclonal 
HPGD custom made  
canine-specific antibody  
(Gram et al., 2013) 
Eurogentec 
Seraing 
Belgium 
IgG against canine-specific peptide 
sequence HFQDYETTPFHAKTQ,  
C-terminal amino acids 252-266 
1:750 guinea pig 
polyclonal 
EP2 catalog no. 
101770 
Cayman Chemicals 
MI, USA 
IgG against human EP2, C-terminal 
amino acids 335-358 
1:200 rabbit 
polyclonal 
EP4 catalog no. 
101775 
Cayman Chemicals 
MI, USA 
IgG against human EP4, C-terminal 
amino acids 459-488 
1:100 rabbit 
polyclonal 
Isotype control IgG Vector Laboratories Inc., 
Burlingame, CA, USA  
  
- 
Same protein 
concentration as primary 
antibody 
mouse 
Isotype control IgG  Vector Laboratories Inc., 
Burlingame, CA, USA  
 
- 
Same protein 
concentration as primary 
antibody 
rabbit  
Isotype control IgG  Vector Laboratories Inc., 
Burlingame, CA, USA  
 
- 
Same protein 
concentration as primary 
antibody 
 goat 
Isotype control  IgG Vector Laboratories Inc., 
Burlingame, CA, USA  
 
- 
Same protein 
concentration as primary 
antibody 
guinea pig  
Table	  2	  
